Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motesanib + Paclitaxel + Carboplatin in Asian Advanced Non-Squamous NSCLC
NCT02629848Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jul 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of motesanib in non-small cell lung cancer (NSCLC), sponsored by Takeda. Started Jul 2012; status: terminated.
02
Drugs
motesanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02629848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02629848.